PURA and USMJ Announce EVERx CBD Infused Gummies Launch In Conjunction With Annual 420 Celebration Next Week

Dallas, TX -- April 11, 2017 -- InvestorsHub NewsWire -- Puration, Inc. (USTOC: PURA) and North American Cannabis Holdings, Inc. (USOTC: USMJ) more commonly known as “USMJ,” today announced the launch of a CBD infused sports nutrition supplement gummy under the EVERx brand name.  The EVERx CBD Infused Gummies for Post Workout Recovery will be available for the first time at USMJ’s AmeriCanna Cafe display at the upcoming Southwest Cannabis Conference and Expo In Fort Worth, Texas April 22-23.  An online presentation of the new EVERx CBD Infused Gummies for Post Workout Recovery will be published Thursday, April 13, 2017.
 
The EVERx Brand is owned by USMJ.  PURA has licensed the production of select products under the EVERx Brand.  PURA has licensed a U.S. Patented process for cannabis extraction and has entered into a number of agreements to infuse its proprietary CBD extract into food and beverage products.  PURA recently introduce EVERx CBD Infused Bottled Sports Water and EVERx Alkaline Bottled Sports Water at Arnold Schwarzenegger’s Annual Arnold Sports Festival.  EVERx CBD Infused Bottles Sports Water and EVERx Alkaline Bottled Sports Water will both be avaialbe along with the new EVERx CBD Infused Gummies For Post Workout Recovery at the upcoming Southwest Cannabis Conference and Expo in Fort Worth, Texas April 22-23.

The EVERx CBD Infused Bottled Sports Water and the EVERx CBD Alakaline Bottled Sports water are both bottled by Alkame Holdings, Inc. (USOTC: ALKM) and both include the ALKM's US Patented water molecule.
 
Learn More About USMJ:                   growusmj.com
Learn More About PURA:                   purationinc.com
Learn More About ALKM:                   alkamewater.com
 
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
 
Puration Contact:
Brian Shibley, CEO
[e-mail]
[phone]
 
North American Cannabis Holdings Contact:
Steven Rash 
Phone: [phone] 
Email: [e-mail]